DelleD – LaFleur obtains a public funding of 500k€ for the development of its cannabis-based drug for the treatment of cancers refractory to available therapies
At a time when France needs to support the strategic health sector, DelleD announces that it has obtained €500k in funding for its research project on cancer treatment. LAFLEUR: A LABORATORY FOR PLANT INNOVATION IN HEALTH Près de 400.000 personnes sont touchées par un cancer en France et le nombre de décès avoisine 160.000 personnes …
